Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion

Delcath Systems (DCTH) Financials

Delcath Systems logo
$14.37 +0.29 (+2.06%)
Closing price 10/19/2026 04:00 PM Eastern
Extended Trading
$14.37 0.00 (0.00%)
As of 08:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Delcath Systems

Annual Income Statements for Delcath Systems

This table shows Delcath Systems' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-15 -18 -45 -19 -18 -48 -26 -37 -48 -26 2.70
Consolidated Net Income / (Loss)
-15 -18 -45 -19 -8.88 -48 -26 -37 -48 -26 2.70
Net Income / (Loss) Continuing Operations
-15 -18 -45 -19 -8.88 -48 -26 -37 -48 -26 2.70
Total Pre-Tax Income
-15 -18 -25 -18 -8.88 -24 -26 -37 -48 -26 3.51
Total Operating Income
-15 -16 -18 -27 -20 -21 -25 -34 -38 -12 0.66
Total Gross Profit
1.29 1.44 2.01 2.40 0.86 1.01 2.88 2.03 1.43 31 73
Total Revenue
1.75 1.99 2.72 3.41 1.58 1.65 3.56 2.72 2.07 37 85
Operating Revenue
1.75 1.99 2.72 3.41 1.58 1.65 3.56 2.72 2.07 37 85
Total Cost of Revenue
0.46 0.55 0.70 1.01 0.72 0.64 0.67 0.69 0.64 6.19 12
Operating Cost of Revenue
0.46 0.55 0.70 1.01 0.72 0.64 0.67 0.69 0.64 6.19 12
Total Operating Expenses
16 18 20 29 21 22 27 36 40 43 73
Selling, General & Admin Expense
10 9.43 9.68 9.82 11 11 14 17 22 30 44
Research & Development Expense
6.49 8.45 10 20 9.49 11 14 19 18 14 29
Total Other Income / (Expense), net
0.50 -1.55 -6.60 8.92 11 -2.85 -1.12 -2.69 -9.44 -14 2.85
Interest & Investment Income
- - -22 -7.96 -4.75 -0.18 -1.19 -2.69 -1.44 0.13 2.92
Other Income / (Expense), net
0.56 13 15 17 16 -2.68 0.07 0.00 -8.00 -14 -0.07
Income Tax Expense
- - - - - - - - - 0.00 0.81
Basic Earnings per Share
($5,096.00) ($3,707.00) ($3,250.00) ($504.00) ($342.83) ($8.35) ($3.59) ($4.12) ($2.94) ($0.93) $0.08
Weighted Average Basic Shares Outstanding
2.89K 4.85K 14.04K 38.15K 25.90K 2.90M 7.15M 8.86M 16.23M 28.51M 35.82M
Diluted Earnings per Share
($5,096.00) ($3,707.00) ($3,250.00) ($504.00) ($342.83) ($8.35) ($3.59) ($4.12) ($2.94) ($0.93) $0.07
Weighted Average Diluted Shares Outstanding
2.89K 4.85K 14.04K 38.15K 25.90K 2.90M 7.15M 8.86M 16.23M 28.51M 39.92M
Weighted Average Basic & Diluted Shares Outstanding
2.89K 4.85K 14.04K 38.15K 25.90K 2.90M 7.15M 10.06M 24.56M 33.40M 34.75M

Quarterly Income Statements for Delcath Systems

This table shows Delcath Systems' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-11 -11 -14 1.86 -3.40 1.07 2.70 0.83 -1.90 -1.07 2.67
Consolidated Net Income / (Loss)
-11 -11 -14 1.86 -3.40 1.07 2.70 0.83 -1.90 -1.07 2.67
Net Income / (Loss) Continuing Operations
-11 -11 -14 1.86 -3.40 1.07 2.70 0.83 -1.90 -1.07 2.67
Total Pre-Tax Income
-11 -11 -14 1.86 -3.35 1.26 3.21 0.38 -1.33 -0.91 3.16
Total Operating Income
-11 -10 -3.91 -1.26 3.04 0.64 2.59 -0.39 -2.18 -1.64 2.40
Total Gross Profit
0.37 2.24 6.25 9.56 13 17 21 18 18 21 26
Total Revenue
0.54 3.14 7.77 11 15 20 24 21 21 25 29
Operating Revenue
0.54 3.14 7.77 11 15 20 24 21 21 25 29
Total Cost of Revenue
0.17 0.90 1.52 1.64 2.13 2.85 3.32 2.62 3.01 3.74 2.99
Operating Cost of Revenue
0.17 0.90 1.52 1.64 2.13 2.85 3.32 2.62 3.01 3.74 2.99
Total Operating Expenses
12 13 10 11 9.94 16 18 18 20 23 24
Selling, General & Admin Expense
6.96 8.81 6.77 6.95 7.02 11 11 10 11 13 13
Research & Development Expense
4.71 3.70 3.39 3.87 2.91 5.01 6.88 7.99 9.37 9.82 10
Total Other Income / (Expense), net
0.24 -0.81 -9.84 3.12 -6.38 0.62 0.62 0.76 0.85 0.73 0.76
Interest & Investment Income
0.02 -0.20 -0.08 0.11 0.30 0.62 0.65 0.80 0.86 0.79 0.78
Other Income / (Expense), net
0.23 -0.61 -9.76 3.01 -6.68 0.00 -0.03 -0.03 -0.00 -0.06 -0.02
Income Tax Expense
- 0.00 0.00 0.00 - 0.20 0.51 -0.46 0.56 0.16 0.49
Basic Earnings per Share
($0.45) ($0.45) ($0.48) $0.06 ($0.06) $0.03 $0.08 $0.02 ($0.05) ($0.03) $0.07
Weighted Average Basic Shares Outstanding
16.23M 24.89M 28.36M 28.74M 28.51M 34.64M 35.79M 36.38M 35.82M 36.02M 35.89M
Diluted Earnings per Share
($0.45) ($0.45) ($0.48) $0.06 ($0.06) $0.03 $0.07 $0.02 ($0.05) ($0.03) $0.07
Weighted Average Diluted Shares Outstanding
16.23M 24.89M 28.36M 32.35M 28.51M 39.51M 40.26M 40.06M 39.92M 36.02M 39.76M
Weighted Average Basic & Diluted Shares Outstanding
24.56M 27.79M 28.00M 31.97M 33.40M 34.83M 34.98M 35.31M 34.75M 34.52M 34.70M

Annual Cash Flow Statements for Delcath Systems

This table details how cash moves in and out of Delcath Systems' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-7.86 -8.20 -26 -1.57 6.61 19 -1.93 -15 0.87 20 11
Net Cash From Operating Activities
-16 -14 -15 -15 -24 -23 -23 -25 -31 -19 23
Net Cash From Continuing Operating Activities
-16 -14 -15 -15 -24 -23 -23 -25 -31 -19 23
Net Income / (Loss) Continuing Operations
-15 -18 -45 -19 -8.88 -24 -26 -37 -48 -26 2.70
Consolidated Net Income / (Loss)
-15 -18 -45 -19 -8.88 -24 -26 -37 -48 -26 2.70
Depreciation Expense
0.62 0.31 0.31 0.44 0.21 0.17 0.15 0.13 0.13 0.13 0.24
Amortization Expense
0.00 14 22 2.83 4.50 0.03 0.32 0.77 0.90 -0.03 -1.59
Non-Cash Adjustments To Reconcile Net Income
0.11 -12 5.35 -11 -14 6.77 8.34 8.54 16 23 24
Changes in Operating Assets and Liabilities, net
-2.44 1.54 2.51 12 -5.56 -5.81 -5.76 2.11 -0.91 -16 -3.07
Net Cash From Investing Activities
0.01 -1.35 -0.52 -0.08 -0.02 -0.78 -0.14 -0.21 -20 -0.98 -27
Net Cash From Continuing Investing Activities
0.01 -1.35 -0.52 -0.08 -0.02 -0.78 -0.14 -0.21 -20 -0.98 -27
Purchase of Property, Plant & Equipment
-0.17 -0.26 -0.52 -0.08 -0.02 -0.78 -0.14 -0.21 -0.06 -0.56 -1.55
Purchase of Investments
- - - - - - - 0.00 -20 -52 -93
Sale and/or Maturity of Investments
- - - - - - - 0.00 0.00 52 68
Net Cash From Financing Activities
8.66 7.41 -11 13 30 42 21 10 52 39 15
Net Cash From Continuing Financing Activities
8.66 7.41 -11 13 30 42 21 10 52 39 15
Repayment of Debt
0.00 0.00 0.00 -4.87 - 0.00 0.00 -0.71 -6.31 -11 0.00
Repurchase of Common Equity
- - - - 0.00 -0.00 - - - 0.00 -6.00
Issuance of Common Equity
8.66 2.38 0.02 11 0.00 41 0.00 11 23 7.02 0.48
Other Financing Activities, net
0.00 -26 -9.89 0.52 0.04 1.83 6.39 0.00 35 43 21
Other Net Changes in Cash
- - - - 0.01 - - -0.12 0.06 -0.03 0.07
Cash Interest Paid
- - - - 0.00 0.01 0.68 1.87 1.46 1.24 0.00
Cash Income Taxes Paid
- - - - - - - - - 0.00 1.55

Quarterly Cash Flow Statements for Delcath Systems

This table details how cash moves in and out of Delcath Systems' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
-28 -0.89 2.97 -6.47 24 -20 22 7.39 1.64 -2.14 6.21
Net Cash From Operating Activities
-8.18 -9.58 -4.45 -3.64 -1.01 2.20 7.29 4.77 8.25 0.86 5.71
Net Cash From Continuing Operating Activities
-8.00 -9.58 -4.45 -3.70 -0.94 2.20 7.29 4.77 8.25 0.86 5.71
Net Income / (Loss) Continuing Operations
-11 -11 -14 1.86 -3.40 1.07 2.70 0.83 -1.90 -1.07 2.67
Consolidated Net Income / (Loss)
-11 -11 -14 1.86 -3.40 1.07 2.70 0.83 -1.90 -1.07 2.67
Depreciation Expense
0.04 0.03 0.03 0.03 0.04 0.04 0.05 0.06 0.08 0.10 0.11
Amortization Expense
0.31 0.05 0.04 -0.06 -0.04 -0.28 -0.43 -0.45 -0.43 -0.41 -0.38
Non-Cash Adjustments To Reconcile Net Income
1.73 3.60 13 -0.83 7.46 6.86 7.21 5.65 4.51 4.95 5.12
Changes in Operating Assets and Liabilities, net
1.05 -2.14 -3.67 -4.71 -5.00 -5.49 -2.24 -1.33 5.98 -2.71 -1.81
Net Cash From Investing Activities
-20 4.66 10 -0.70 -15 -25 -0.42 -0.47 -0.56 -0.57 -0.50
Net Cash From Continuing Investing Activities
-20 4.66 10 -0.70 -15 -25 -0.42 -0.47 -0.56 -0.57 -0.50
Purchase of Property, Plant & Equipment
-0.02 -0.01 -0.10 -0.22 -0.23 -0.14 -0.40 -0.46 -0.55 -0.57 -0.50
Purchase of Investments
-20 -10 -10 -11 -21 -30 -21 -10 -32 -16 -32
Sale and/or Maturity of Investments
- 15 21 11 5.69 5.05 21 10 32 16 32
Net Cash From Financing Activities
0.00 4.02 -2.85 -2.14 40 3.25 15 3.10 -5.94 -2.38 0.96
Net Cash From Continuing Financing Activities
0.00 4.02 -2.85 -2.14 40 3.25 15 3.10 -5.94 -2.38 0.96
Repurchase of Common Equity
- - - - - 0.00 - - - -3.00 -0.01
Other Financing Activities, net
0.00 0.00 0.43 0.19 42 3.02 15 2.86 0.06 0.23 0.97
Other Net Changes in Cash
0.03 0.02 -0.01 0.01 -0.05 0.06 0.13 -0.01 -0.10 -0.05 0.04

Annual Balance Sheets for Delcath Systems

This table presents Delcath Systems' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
16 35 8.89 6.84 14 35 33 18 39 77 124
Total Current Assets
15 34 7.59 5.92 13 32 31 16 37 74 120
Cash & Equivalents
13 4.41 4.00 2.52 10 29 23 7.67 13 32 43
Short-Term Investments
- - - - - - - 0.00 20 21 48
Accounts Receivable
0.28 0.40 0.32 0.59 0.02 0.06 0.04 0.37 0.24 11 12
Inventories, net
0.76 0.66 1.25 0.86 0.65 0.86 1.41 2.00 3.32 6.93 10
Prepaid Expenses
0.96 0.70 0.70 0.90 1.76 2.67 2.74 1.97 1.09 2.70 6.50
Plant, Property, & Equipment, net
1.13 1.08 1.30 0.93 0.74 1.35 1.35 1.42 1.35 1.79 3.17
Total Noncurrent Assets
0.00 0.00 0.00 0.00 0.86 0.95 0.62 0.29 0.10 1.04 0.94
Other Noncurrent Operating Assets
- - - 0.00 0.86 0.95 0.62 0.29 0.10 1.04 0.94
Total Liabilities & Shareholders' Equity
16 35 8.89 6.84 14 35 33 18 39 77 124
Total Liabilities
7.13 37 8.21 22 21 13 21 24 23 7.84 12
Total Current Liabilities
6.31 36 7.81 18 16 10 5.95 15 16 6.14 11
Accounts Payable
0.28 0.59 3.85 7.72 4.53 1.77 0.64 2.02 1.01 0.96 2.66
Accrued Expenses
2.24 3.41 3.41 7.96 6.95 5.24 4.11 4.69 5.25 5.08 8.19
Other Current Liabilities
3.79 19 0.56 0.03 4.03 0.50 0.42 0.19 0.04 0.11 0.10
Total Noncurrent Liabilities
0.82 0.63 0.40 4.03 4.58 2.52 15 8.99 6.39 1.70 1.46
Other Noncurrent Operating Liabilities
0.82 0.60 0.40 0.63 0.20 0.45 0.21 1.14 6.39 1.70 1.46
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
8.60 -1.49 0.68 -15 -6.36 22 12 -5.86 16 69 111
Total Preferred & Common Equity
8.60 -1.49 0.68 -15 -6.36 22 12 -5.86 16 69 111
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
8.60 -1.49 0.68 -15 -6.36 22 12 -5.86 16 69 111
Common Stock
270 278 326 329 365 418 433 452 521 600 639
Retained Earnings
-261 -279 -325 -344 -371 -395 -421 -457 -505 -532 -529
Accumulated Other Comprehensive Income / (Loss)
-0.01 -0.04 0.04 0.05 0.03 -0.10 0.02 -0.08 0.14 0.08 0.58

Quarterly Balance Sheets for Delcath Systems

This table presents Delcath Systems' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
31 21 48 36 34 32 87 117 124 125 137
Total Current Assets
29 19 46 34 31 29 84 113 121 120 131
Cash & Equivalents
24 15 40 12 15 8.32 13 34 42 41 48
Short-Term Investments
- - - 15 5.12 5.68 46 47 47 48 48
Accounts Receivable
0.46 0.13 0.21 1.56 3.73 6.94 14 16 14 14 16
Inventories, net
2.34 2.48 2.67 3.63 6.32 6.64 7.13 11 11 9.81 12
Prepaid Expenses
1.96 2.28 2.71 1.28 1.45 1.31 4.38 6.12 7.21 7.00 6.98
Plant, Property, & Equipment, net
1.39 1.40 1.37 1.34 1.42 1.73 1.95 2.40 2.72 3.66 4.02
Total Noncurrent Assets
0.19 0.18 0.11 1.12 1.09 1.07 1.02 0.99 0.97 0.91 2.46
Other Noncurrent Operating Assets
0.19 0.18 0.11 1.12 1.09 1.07 1.02 0.99 0.97 0.91 2.46
Total Liabilities & Shareholders' Equity
31 21 48 36 34 32 87 117 124 125 137
Total Liabilities
25 21 23 21 30 23 7.09 12 9.45 12 16
Total Current Liabilities
13 11 14 13 12 22 5.29 10 8.01 11 13
Accounts Payable
2.43 0.97 0.75 1.49 3.28 0.94 1.62 4.72 2.13 3.46 4.01
Accrued Expenses
7.12 5.55 5.23 4.40 4.42 5.71 3.56 5.60 5.77 7.14 9.07
Other Current Liabilities
0.09 0.09 0.04 0.10 0.10 13 0.11 0.12 0.11 0.09 0.20
Total Noncurrent Liabilities
12 10 8.88 8.14 17 1.53 1.80 1.46 1.44 1.43 2.59
Other Noncurrent Operating Liabilities
6.10 4.93 6.88 8.14 17 1.53 1.80 1.46 1.44 1.43 2.59
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-13 -0.24 25 15 4.19 8.57 80 105 115 113 121
Total Preferred & Common Equity
-13 -0.24 25 15 4.19 8.57 80 105 115 113 121
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-13 -0.24 25 15 4.19 8.57 80 105 115 113 121
Common Stock
453 474 519 531 534 537 610 632 641 642 648
Retained Earnings
-466 -474 -494 -516 -530 -528 -530 -528 -527 -530 -527
Accumulated Other Comprehensive Income / (Loss)
-0.06 -0.06 -0.06 0.16 0.01 0.01 0.38 0.59 0.88 0.57 0.26

Annual Metrics And Ratios for Delcath Systems

This table displays calculated financial ratios and metrics derived from Delcath Systems' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
63.42% 14.02% 36.30% 25.49% -53.62% 4.18% 115.98% -23.52% -24.05% 1,701.69% 129.08%
EBITDA Growth
14.48% 177.79% 72.20% -136.83% 108.39% -4,194.49% -0.86% -37.34% -37.03% 41.58% 97.13%
EBIT Growth
15.64% 75.01% 16.34% -232.82% 59.43% -479.95% -2.01% -38.38% -36.41% 42.66% 102.23%
NOPAT Growth
21.21% -8.09% -10.49% -49.03% 26.46% -7.01% -15.15% -38.00% -12.79% 67.50% 105.84%
Net Income Growth
15.40% -22.22% -151.05% 57.40% 53.81% -444.12% 46.91% -42.34% -30.60% 44.66% 110.23%
EPS Growth
15.40% -22.22% -151.05% 57.40% 31.98% 97.56% 57.01% -14.76% 28.64% 68.37% 107.53%
Operating Cash Flow Growth
-5.58% 13.44% -8.34% 4.33% -60.80% 3.47% 1.15% -10.38% -25.25% 40.22% 220.53%
Free Cash Flow Firm Growth
27.34% 148.29% -744.78% 74.50% -123.06% -56.06% 9.26% 6.26% -5.08% -38.99% 86.48%
Invested Capital Growth
-72.38% -395.33% 76.59% -254.69% 11.77% 67.83% 113.49% -415.85% -230.01% 335.87% 30.10%
Revenue Q/Q Growth
9.19% 13.57% 1.04% 10.33% -24.22% -0.66% 82.03% -35.11% -4.57% 64.30% 7.07%
EBITDA Q/Q Growth
-18.86% 1,136.37% 22.82% -166.50% 103.36% -299.68% 9.70% -12.02% -6.54% 21.79% 61.46%
EBIT Q/Q Growth
-16.95% 54.05% 76.42% -290.70% 82.04% -415.83% 8.90% -10.43% -7.54% 21.93% 165.70%
NOPAT Q/Q Growth
-6.60% -0.95% -1.92% 21.42% 13.65% -12.96% 8.65% -10.43% -9.93% 53.61% -91.37%
Net Income Q/Q Growth
-17.13% -23.27% -31.31% 30.35% 72.46% -942.33% 50.18% -9.36% -5.92% 22.68% 125.38%
EPS Q/Q Growth
-17.13% -23.27% -31.31% 30.35% -86.11% 1.53% 35.20% -13.81% 11.18% 29.55% 16.67%
Operating Cash Flow Q/Q Growth
-7.24% 4.15% -0.81% 11.43% -17.51% 1.41% -4.58% -5.63% -2.69% 27.74% 69.78%
Free Cash Flow Firm Q/Q Growth
5.38% -49.94% 14.65% 52.63% -483.24% 37.66% 1.17% -3.84% -3.01% -45.57% 82.27%
Invested Capital Q/Q Growth
-27.13% 14.47% -56.38% -36.64% 55.04% 19.40% 134.03% 34.01% -12.68% 553.46% -22.18%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
73.55% 72.39% 74.18% 70.38% 54.49% 61.12% 81.13% 74.77% 69.25% 83.37% 86.16%
EBITDA Margin
-803.03% 547.84% 692.15% -203.14% 36.77% -1,445.26% -674.94% -1,211.95% -2,186.73% -70.90% -0.89%
Operating Margin
-870.64% -825.30% -669.06% -794.57% -1,260.00% -1,294.23% -690.04% -1,245.05% -1,849.01% -33.36% 0.77%
EBIT Margin
-838.35% -183.73% -112.78% -299.12% -261.71% -1,456.93% -688.13% -1,245.05% -2,236.32% -71.18% 0.69%
Profit (Net Income) Margin
-841.67% -902.16% -1,661.77% -564.19% -561.96% -2,935.12% -721.49% -1,342.70% -2,308.86% -70.92% 3.17%
Tax Burden Percent
99.94% 99.91% 182.18% 105.91% 99.98% 200.00% 100.00% 99.92% 100.12% 100.11% 76.92%
Interest Burden Percent
100.46% 491.48% 808.79% 178.10% 214.78% 100.73% 104.85% 107.93% 103.12% 99.53% 594.92%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 23.08%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -194.43% 2.84%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -147.60% -0.19%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 131.99% 0.16%
Return on Equity (ROE)
-109.95% -505.44% 11,112.56% 269.57% 83.39% -614.62% -150.74% -1,198.36% -961.44% -62.44% 3.00%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -3,562.71% 0.00% 0.00% -198.39% -23.32%
Operating Return on Assets (OROA)
-74.16% -14.36% -13.88% -129.57% -39.28% -98.19% -72.21% -132.79% -163.54% -45.97% 0.59%
Return on Assets (ROA)
-74.46% -70.51% -204.49% -244.38% -84.34% -197.81% -75.71% -143.21% -168.85% -45.81% 2.70%
Return on Common Equity (ROCE)
-109.95% -505.44% 11,112.56% 269.57% 83.39% -614.62% -150.74% -1,198.36% -961.44% -62.44% 3.00%
Return on Equity Simple (ROE_SIMPLE)
-170.96% 1,206.11% 0.00% 128.67% 139.67% -218.82% -214.60% 623.11% -302.20% -38.38% 0.00%
Net Operating Profit after Tax (NOPAT)
-11 -12 -13 -19 -14 -15 -17 -24 -27 -8.69 0.51
NOPAT Margin
-609.44% -577.71% -468.34% -556.20% -882.00% -905.96% -483.03% -871.54% -1,294.31% -23.35% 0.60%
Net Nonoperating Expense Percent (NNEP)
-24.53% -41.75% -273.70% -7.93% 104.01% -191.19% -44.53% -343.69% -226.64% -46.83% 3.04%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - -103.09% -12.64% 0.46%
Cost of Revenue to Revenue
26.45% 27.61% 25.82% 29.62% 45.51% 38.88% 18.87% 25.23% 30.75% 16.63% 13.84%
SG&A Expenses to Revenue
572.93% 473.59% 356.69% 288.20% 713.86% 674.85% 383.60% 636.37% 1,070.70% 79.43% 51.07%
R&D to Revenue
371.27% 424.10% 386.56% 576.75% 600.63% 680.50% 387.57% 683.45% 847.55% 37.29% 34.31%
Operating Expenses to Revenue
944.19% 897.69% 743.24% 864.95% 1,314.49% 1,355.35% 771.17% 1,319.82% 1,918.26% 116.72% 85.38%
Earnings before Interest and Taxes (EBIT)
-15 -3.66 -3.06 -10 -4.14 -24 -24 -34 -46 -26 0.59
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-14 11 19 -6.92 0.58 -24 -24 -33 -45 -26 -0.76
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.27 0.00 0.38 0.00 0.00 3.34 4.77 0.00 5.81 5.60 3.21
Price to Tangible Book Value (P/TBV)
1.27 0.00 0.38 0.00 0.00 3.34 4.77 0.00 5.81 5.60 3.21
Price to Revenue (P/Rev)
6.23 1.01 0.10 0.26 0.42 44.82 16.04 11.38 44.41 10.35 4.18
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 132.10
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.76%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 72.41 0.00 0.00 21.38 13.16
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 28.56 12.85 12.81 33.59 8.92 3.12
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 450.22
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 523.22
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 11.80
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 -8.96 0.00 -0.14 -0.31 0.09 1.31 -2.68 0.64 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 -0.31 0.00 1.26 -1.34 0.00 0.00 0.00
Financial Leverage
-1.24 -4.35 29.16 0.48 0.46 -2.22 -1.12 -1.22 -1.86 -0.89 -0.80
Leverage Ratio
1.48 7.17 -54.34 -1.10 -0.99 3.11 1.99 8.37 5.69 1.36 1.11
Compound Leverage Factor
1.48 35.23 -439.51 -1.96 -2.12 3.13 2.09 9.03 5.87 1.36 6.62
Debt to Total Capital
0.00% 112.57% 0.00% -15.80% -45.90% 8.31% 56.67% 159.61% 39.15% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 112.57% 0.00% -15.80% 0.00% 8.31% 2.25% 79.83% 39.15% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% -45.90% 0.00% 54.42% 79.78% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% -12.57% 100.00% 115.80% 145.90% 91.69% 43.33% -59.61% 60.85% 100.00% 100.00%
Debt to EBITDA
0.00 1.22 0.00 -0.29 3.44 -0.08 -0.65 -0.48 -0.22 0.00 0.00
Net Debt to EBITDA
0.00 -1.68 0.00 0.22 -14.08 1.12 0.47 -0.12 0.50 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 3.44 0.00 -0.63 -0.24 0.00 0.00 0.00
Debt to NOPAT
0.00 -1.16 0.00 -0.11 -0.14 -0.13 -0.91 -0.66 -0.38 0.00 0.00
Net Debt to NOPAT
0.00 1.59 0.00 0.08 0.59 1.79 0.66 -0.16 0.84 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 -0.14 0.00 -0.87 -0.33 0.00 0.00 0.00
Altman Z-Score
-24.66 -11.41 -52.01 -76.84 -37.68 -13.92 -17.59 -41.08 -19.16 20.14 13.01
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.31 0.95 0.97 0.33 0.79 3.22 5.23 1.10 2.26 12.01 10.92
Quick Ratio
2.04 0.13 0.55 0.17 0.63 2.85 3.84 0.55 1.99 10.44 9.39
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-8.97 4.33 -28 -7.12 -16 -25 -22 -21 -22 -31 -4.16
Operating Cash Flow to CapEx
0.00% -5,508.91% -2,938.55% -19,384.21% -98,704.17% -2,924.30% -15,806.99% -11,937.80% -53,881.03% -3,341.86% 1,455.46%
Free Cash Flow to Firm to Interest Expense
-133.81 0.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-245.07 -0.99 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-244.93 -1.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.09 0.08 0.12 0.43 0.15 0.07 0.10 0.11 0.07 0.65 0.85
Accounts Receivable Turnover
7.75 5.86 7.54 7.55 5.21 42.21 70.40 13.26 6.80 6.68 7.53
Inventory Turnover
0.84 0.78 0.73 0.96 0.95 0.85 0.59 0.40 0.24 1.21 1.37
Fixed Asset Turnover
1.19 1.80 2.28 3.07 1.90 1.58 2.63 1.96 1.49 23.68 34.40
Accounts Payable Turnover
0.90 1.25 0.32 0.17 0.12 0.20 0.56 0.52 0.42 6.27 6.52
Days Sales Outstanding (DSO)
47.11 62.30 48.40 48.32 70.00 8.65 5.19 27.52 53.65 54.60 48.46
Days Inventory Outstanding (DIO)
436.89 470.19 496.73 380.92 383.78 430.30 616.58 907.18 1,528.98 302.45 265.85
Days Payable Outstanding (DPO)
407.66 291.34 1,155.92 2,091.06 3,108.85 1,798.48 656.02 706.59 870.83 58.19 55.99
Cash Conversion Cycle (CCC)
76.35 241.15 -610.79 -1,661.83 -2,655.07 -1,359.53 -34.25 228.11 711.79 298.86 258.33
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-4.01 -20 -4.65 -16 -15 -4.68 0.63 -1.99 -6.58 16 20
Invested Capital Turnover
-0.55 -0.17 -0.22 -0.32 -0.10 -0.17 -1.76 -3.99 -0.48 8.33 4.78
Increase / (Decrease) in Invested Capital
-1.68 -16 15 -12 1.94 9.86 5.31 -2.62 -4.58 22 4.67
Enterprise Value (EV)
-1.73 -16 -5.07 -0.64 -7.52 47 46 35 69 332 266
Market Capitalization
11 2.02 0.26 0.90 0.67 74 57 31 92 385 357
Book Value per Share
$0.40 ($0.68) $0.26 ($1.66) ($0.29) $5.36 $1.62 ($0.68) $0.72 $2.15 $3.15
Tangible Book Value per Share
$0.40 ($0.68) $0.26 ($1.66) ($0.29) $5.36 $1.62 ($0.68) $0.72 $2.15 $3.15
Total Capital
8.60 12 0.68 -13 -4.36 24 28 9.83 26 69 111
Total Debt
0.00 13 0.00 2.04 2.00 2.00 16 16 10 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 2.00 0.00 15 7.84 0.00 0.00 0.00
Net Debt
-13 -18 -5.32 -1.54 -8.18 -27 -11 3.87 -22 -53 -91
Capital Expenditures (CapEx)
-0.01 0.26 0.52 0.08 0.02 0.78 0.14 0.21 0.06 0.56 1.55
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-4.32 -20 -5.55 -13 -14 -4.45 -1.13 -2.56 -1.64 14 18
Debt-free Net Working Capital (DFNWC)
8.29 11 -0.23 -9.79 -3.38 24 26 9.27 31 68 109
Net Working Capital (NWC)
8.29 -1.94 -0.23 -12 -3.38 22 25 1.42 21 68 109
Net Nonoperating Expense (NNE)
4.06 6.46 32 0.27 -5.06 33 8.48 13 21 18 -2.19
Net Nonoperating Obligations (NNO)
-13 -18 -5.32 -1.54 -8.18 -27 -11 3.87 -22 -53 -91
Total Depreciation and Amortization (D&A)
0.62 15 22 3.27 4.72 0.19 0.47 0.90 1.02 0.10 -1.35
Debt-free, Cash-free Net Working Capital to Revenue
-247.17% -1,018.67% -204.38% -392.46% -858.23% -270.53% -31.90% -94.01% -79.61% 38.66% 20.58%
Debt-free Net Working Capital to Revenue
474.47% 572.49% -8.29% -287.44% -213.73% 1,476.49% 726.27% 340.79% 1,494.43% 181.74% 127.40%
Net Working Capital to Revenue
474.47% -97.34% -8.29% -347.26% -213.73% 1,354.98% 708.80% 52.23% 1,002.91% 181.74% 127.40%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($1,783,600,000.00) ($1,297,275,000.00) ($2,275,000.00) ($504.00) ($1,047.00) ($8.35) ($3.59) ($4.12) ($2.94) ($0.93) $0.08
Adjusted Weighted Average Basic Shares Outstanding
0.00 1.00 1.24K 55.00 72.77K 2.90M 7.91M 8.86M 16.23M 28.51M 35.82M
Adjusted Diluted Earnings per Share
($1,783,600,000.00) ($1,297,275,000.00) ($2,275,000.00) ($504.00) ($1,047.00) ($8.35) ($3.59) ($4.12) ($2.94) ($0.93) $0.07
Adjusted Weighted Average Diluted Shares Outstanding
0.00 1.00 1.24K 55.00 72.77K 2.90M 7.91M 8.86M 16.23M 28.51M 39.92M
Adjusted Basic & Diluted Earnings per Share
$0.00 ($1,297,275,000.00) ($2,275,000.00) ($504.00) ($1,047.00) $0.00 ($3.59) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 20.00 38.15K 25.90K 6.25M 7.15M 10.06M 24.56M 33.40M 34.75M
Normalized Net Operating Profit after Tax (NOPAT)
-11 -12 -13 -19 -14 -15 -17 -24 -27 -8.69 0.51
Normalized NOPAT Margin
-609.44% -577.71% -468.34% -556.20% -882.00% -905.96% -483.03% -871.54% -1,294.31% -23.35% 0.60%
Pre Tax Income Margin
-842.19% -903.01% -912.15% -532.73% -562.09% -1,467.56% -721.49% -1,343.80% -2,306.00% -70.84% 4.12%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-218.60 -0.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
-158.91 -0.80 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-218.45 -0.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-158.76 -0.82 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% -0.22% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% -0.22% 0.00% 0.00% 0.00% 0.00% 222.22%

Quarterly Metrics And Ratios for Delcath Systems

This table displays calculated financial ratios and metrics derived from Delcath Systems' official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - 33,403,138.00 34,826,183.00 34,981,253.00 - 34,746,187.00 34,521,647.00
DEI Adjusted Shares Outstanding
- - - - - 33,403,138.00 34,826,183.00 34,981,253.00 - 34,746,187.00 34,521,647.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - 0.03 0.08 0.02 - -0.03 0.08
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-15.52% 425.80% 1,468.89% 2,480.65% 2,701.48% 530.26% 211.05% 83.60% 37.27% 26.33% 20.60%
EBITDA Growth
-34.88% -33.67% -105.59% 108.58% 66.02% 103.76% 116.05% -145.72% 32.79% -592.38% -3.08%
EBIT Growth
-41.32% -30.81% -99.90% 108.61% 67.14% 105.93% 118.70% -124.04% 40.97% -362.38% -6.96%
NOPAT Growth
-43.93% -23.46% 51.08% 82.96% 126.88% 107.55% 179.59% 31.79% -171.87% -311.05% -7.19%
Net Income Growth
-31.44% -23.46% -90.79% 109.16% 69.49% 109.62% 119.63% -55.47% 44.20% -200.09% -1.08%
EPS Growth
45.12% 41.56% 17.24% 105.26% 86.67% 106.67% 114.58% -66.67% 16.67% -200.00% 0.00%
Operating Cash Flow Growth
-11.13% -124.77% 53.87% 60.27% 87.70% 122.99% 263.85% 231.10% 919.88% -61.10% -21.68%
Free Cash Flow Firm Growth
-15.83% -375.26% 300.05% 19.62% -499.70% -127.66% -1,067.16% -722.17% 68.95% 87.60% 102.30%
Invested Capital Growth
-230.01% 44.83% -121.36% 41.39% 335.87% 510.82% 313.68% 858.11% 30.10% 9.74% 5.26%
Revenue Q/Q Growth
24.19% 482.37% 147.40% 44.22% 34.82% 31.02% 22.10% -14.87% 0.80% 20.58% 16.56%
EBITDA Q/Q Growth
45.62% 1.50% -25.57% 112.44% -315.37% 110.79% 440.45% -136.82% -216.21% 20.98% 205.34%
EBIT Q/Q Growth
44.44% 1.70% -25.50% 112.56% -312.12% 117.44% 298.13% -116.47% -419.48% 22.50% 240.30%
NOPAT Q/Q Growth
-7.09% 9.08% 61.94% 54.02% 268.97% -74.48% 301.41% -139.40% -78.02% 25.05% 276.52%
Net Income Q/Q Growth
45.25% 0.22% -23.67% 113.57% -282.30% 131.46% 152.29% -69.23% -328.43% 43.57% 349.35%
EPS Q/Q Growth
60.53% 0.00% -6.67% 112.50% -200.00% 150.00% 133.33% -71.43% -350.00% 40.00% 333.33%
Operating Cash Flow Q/Q Growth
10.73% -17.19% 53.56% 18.22% 72.36% 318.99% 231.05% -34.57% 72.84% -89.61% 566.51%
Free Cash Flow Firm Q/Q Growth
27.19% -242.87% 129.92% -207.63% -443.20% -30.16% -27.10% 8.51% 79.48% 48.01% 123.60%
Invested Capital Q/Q Growth
-12.68% 21.04% -116.12% 69.52% 553.46% 37.52% 12.41% 8.15% -22.18% 15.99% 7.83%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
68.27% 71.23% 80.44% 85.36% 85.92% 85.62% 86.26% 87.24% 85.48% 85.05% 89.75%
EBITDA Margin
-1,989.42% -344.98% -175.10% 15.11% -24.13% 2.06% 9.02% -3.90% -12.23% -8.02% 7.25%
Operating Margin
-2,097.22% -327.43% -50.37% -11.24% 20.13% 3.25% 10.72% -1.89% -10.54% -6.55% 8.22%
EBIT Margin
-2,055.29% -346.93% -175.99% 15.32% -24.11% 3.27% 10.58% -2.05% -10.55% -6.78% 8.16%
Profit (Net Income) Margin
-2,066.05% -353.97% -176.94% 16.64% -22.50% 5.40% 11.16% 4.04% -9.15% -4.28% 9.16%
Tax Burden Percent
100.66% 100.20% 99.93% 101.91% 101.58% 84.57% 84.15% 221.33% 142.13% 117.84% 84.46%
Interest Burden Percent
99.86% 101.83% 100.61% 106.59% 91.90% 195.67% 125.39% -89.07% 61.00% 53.57% 132.84%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 15.43% 15.85% -121.33% 0.00% 0.00% 15.54%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 117.31% 18.31% 99.35% -29.53% -35.22% -18.53% 26.92%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 131.93% 16.98% 98.27% -32.88% -34.71% -18.64% 26.19%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% -117.98% -14.09% -86.79% 26.88% 27.83% 14.31% -20.49%
Return on Equity (ROE)
-961.44% -500.09% -2,852.05% -205.01% -0.67% 4.23% 12.56% -2.65% -7.39% -4.22% 6.43%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% -198.39% -129.23% -125.90% -90.51% -23.32% -12.32% -8.16%
Operating Return on Assets (OROA)
-150.30% -47.93% -76.06% 8.75% -15.57% 2.85% 9.86% -2.09% -8.98% -5.78% 6.14%
Return on Assets (ROA)
-151.09% -48.90% -76.48% 9.51% -14.54% 4.72% 10.40% 4.12% -7.79% -3.65% 6.88%
Return on Common Equity (ROCE)
-961.44% -38.78% -2,852.05% -205.01% -0.67% 4.23% 12.56% -2.65% -7.39% -4.22% 6.43%
Return on Equity Simple (ROE_SIMPLE)
0.00% -340.55% -1,343.70% -398.13% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-7.91 -7.19 -2.74 -1.26 2.13 0.54 2.18 -0.86 -1.53 -1.15 2.02
NOPAT Margin
-1,468.05% -229.20% -35.26% -11.24% 14.09% 2.74% 9.02% -4.18% -7.38% -4.58% 6.94%
Net Nonoperating Expense Percent (NNEP)
-34.87% -22.69% -108.71% 14.68% -14.62% 1.34% 1.07% 3.35% -0.51% 0.10% 0.73%
Return On Investment Capital (ROIC_SIMPLE)
-30.52% - - - 3.09% 0.68% 2.08% -0.75% -1.37% -1.02% 1.67%
Cost of Revenue to Revenue
31.73% 28.77% 19.56% 14.64% 14.08% 14.38% 13.74% 12.76% 14.52% 14.95% 10.25%
SG&A Expenses to Revenue
1,291.84% 280.79% 87.11% 62.08% 46.50% 57.07% 47.05% 50.29% 50.81% 52.30% 45.90%
R&D to Revenue
873.65% 117.87% 43.70% 34.52% 19.30% 25.31% 28.49% 38.84% 45.21% 39.31% 35.63%
Operating Expenses to Revenue
2,165.49% 398.66% 130.81% 96.60% 65.79% 82.37% 75.54% 89.13% 96.02% 91.60% 81.53%
Earnings before Interest and Taxes (EBIT)
-11 -11 -14 1.72 -3.64 0.65 2.56 -0.42 -2.19 -1.70 2.38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-11 -11 -14 1.69 -3.64 0.41 2.18 -0.80 -2.54 -2.00 2.11
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.81 8.01 55.48 29.50 5.60 5.30 4.51 3.27 3.21 2.86 3.59
Price to Tangible Book Value (P/TBV)
5.81 8.01 55.48 29.50 5.60 5.30 4.51 3.27 3.21 2.86 3.59
Price to Revenue (P/Rev)
44.41 25.43 19.58 11.17 10.35 7.90 6.74 4.72 4.18 3.57 4.56
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 212.20 313.90 132.10 574.77 816.97
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.47% 0.32% 0.76% 0.17% 0.12%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 21.38 17.17 16.37 11.07 13.16 9.96 13.42
Enterprise Value to Revenue (EV/Rev)
33.59 21.13 18.28 10.64 8.92 6.80 5.59 3.61 3.12 2.58 3.55
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 663.23 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 308.19 0.00 450.22 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 78.34 48.81 523.22 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 80.95 21.65 11.80 11.01 17.29
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.64 0.50 1.07 0.23 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-1.86 -1.73 -5.12 -1.28 -0.89 -0.83 -0.88 -0.82 -0.80 -0.77 -0.78
Leverage Ratio
5.69 3.35 13.91 2.38 1.36 1.30 1.38 1.26 1.11 1.10 1.12
Compound Leverage Factor
5.69 3.41 14.00 2.54 1.25 2.55 1.73 -1.13 0.68 0.59 1.49
Debt to Total Capital
39.15% 33.48% 51.72% 18.92% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
39.15% 33.48% 51.72% 18.92% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
60.85% 66.52% 48.28% 81.08% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
-0.22 -0.15 -0.08 -0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.50 0.41 0.28 0.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
-0.38 -0.26 -0.18 -0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.84 0.71 0.61 0.64 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
-16.16 -16.94 -17.49 -15.61 21.12 29.21 19.31 19.66 12.94 11.74 12.82
Noncontrolling Interest Sharing Ratio
0.00% 92.25% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.26 2.52 2.55 1.34 12.01 15.95 10.88 15.06 10.92 11.24 9.83
Quick Ratio
1.99 2.15 1.92 0.97 10.44 13.78 9.28 12.82 9.39 9.67 8.42
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-3.33 -11 3.41 -3.68 -20 -26 -33 -30 -6.20 -3.22 0.76
Operating Cash Flow to CapEx
-43,042.11% -73,723.08% -4,406.93% -1,685.19% -439.30% 1,573.57% 1,832.41% 1,039.65% 1,499.64% 150.35% 1,135.59%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.07 0.14 0.43 0.57 0.65 0.87 0.93 1.02 0.85 0.85 0.75
Accounts Receivable Turnover
6.80 4.56 6.17 6.34 6.68 6.95 7.18 7.70 7.53 6.44 6.01
Inventory Turnover
0.24 0.45 0.62 0.91 1.21 1.51 1.18 1.26 1.37 1.50 1.11
Fixed Asset Turnover
1.49 3.38 8.41 14.59 23.68 32.74 36.75 35.82 34.40 32.21 29.73
Accounts Payable Turnover
0.42 0.69 1.28 5.01 6.27 5.24 2.48 7.11 6.52 4.99 2.83
Days Sales Outstanding (DSO)
53.65 80.10 59.20 57.55 54.60 52.55 50.83 47.43 48.46 56.70 60.78
Days Inventory Outstanding (DIO)
1,528.98 803.03 588.87 401.34 302.45 241.67 309.51 290.77 265.85 243.66 328.46
Days Payable Outstanding (DPO)
870.83 526.52 284.19 72.86 58.19 69.72 146.95 51.34 55.99 73.10 128.91
Cash Conversion Cycle (CCC)
711.79 356.61 363.88 386.04 298.86 224.50 213.38 286.85 258.33 227.27 260.33
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-6.58 -5.19 -11 -3.42 16 21 24 26 20 23 25
Invested Capital Turnover
-0.48 -0.63 -1.46 -4.89 8.33 6.67 11.01 7.07 4.78 4.04 3.88
Increase / (Decrease) in Invested Capital
-4.58 4.22 -6.15 2.42 22 27 35 29 4.67 2.08 1.26
Enterprise Value (EV)
69 97 217 241 332 366 393 287 266 233 339
Market Capitalization
92 117 233 253 385 425 474 376 357 322 435
Book Value per Share
$0.72 $0.60 $0.15 $0.31 $2.15 $2.40 $3.01 $3.28 $3.15 $3.24 $3.51
Tangible Book Value per Share
$0.72 $0.60 $0.15 $0.31 $2.15 $2.40 $3.01 $3.28 $3.15 $3.24 $3.51
Total Capital
26 22 8.68 11 69 80 105 115 111 113 121
Total Debt
10 7.36 4.49 2.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-22 -20 -15 -12 -53 -59 -81 -89 -91 -89 -96
Capital Expenditures (CapEx)
0.02 0.01 0.10 0.22 0.23 0.14 0.40 0.46 0.55 0.57 0.50
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1.64 0.49 3.69 -4.69 14 20 22 24 18 20 21
Debt-free Net Working Capital (DFNWC)
31 28 24 9.30 68 79 103 113 109 110 117
Net Working Capital (NWC)
21 20 19 7.30 68 79 103 113 109 110 117
Net Nonoperating Expense (NNE)
3.22 3.92 11 -3.12 5.53 -0.53 -0.52 -1.69 0.37 -0.08 -0.65
Net Nonoperating Obligations (NNO)
-22 -20 -15 -12 -53 -59 -81 -89 -91 -89 -96
Total Depreciation and Amortization (D&A)
0.36 0.06 0.07 -0.02 -0.00 -0.24 -0.38 -0.38 -0.35 -0.31 -0.27
Debt-free, Cash-free Net Working Capital to Revenue
-79.61% 10.68% 31.09% -20.73% 38.66% 37.45% 31.38% 29.76% 20.58% 22.41% 22.38%
Debt-free Net Working Capital to Revenue
1,494.43% 600.43% 198.68% 41.06% 181.74% 146.82% 146.71% 141.46% 127.40% 121.15% 122.89%
Net Working Capital to Revenue
1,002.91% 440.74% 160.87% 32.23% 181.74% 146.82% 146.71% 141.46% 127.40% 121.15% 122.89%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.45) ($0.45) ($0.48) $0.06 ($0.06) $0.03 $0.08 $0.02 ($0.05) ($0.03) $0.07
Adjusted Weighted Average Basic Shares Outstanding
16.23M 24.89M 28.36M 28.74M 28.51M 34.64M 35.79M 36.38M 35.82M 36.02M 35.89M
Adjusted Diluted Earnings per Share
($0.45) ($0.45) ($0.48) $0.06 ($0.06) $0.03 $0.07 $0.02 ($0.05) ($0.03) $0.07
Adjusted Weighted Average Diluted Shares Outstanding
16.23M 24.89M 28.36M 32.35M 28.51M 39.51M 40.26M 40.06M 39.92M 36.02M 39.76M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
24.56M 27.79M 28.00M 31.97M 33.40M 34.83M 34.98M 35.31M 34.75M 34.52M 34.70M
Normalized Net Operating Profit after Tax (NOPAT)
-7.91 -7.19 -2.74 -0.88 2.13 0.54 2.18 -0.27 -1.53 -1.15 2.02
Normalized NOPAT Margin
-1,468.05% -229.20% -35.26% -7.87% 14.09% 2.74% 9.02% -1.32% -7.38% -4.58% 6.94%
Pre Tax Income Margin
-2,052.50% -353.27% -177.07% 16.33% -22.15% 6.39% 13.27% 1.82% -6.44% -3.63% 10.84%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 222.22% 1,604.28% 1,693.80%

Financials Breakdown Chart

Key Financial Trends

Delcath Systems’ latest statements show a substantial improvement in operating scale and liquidity compared with 2023 and 2024. However, the company’s earnings remain volatile, and its long-term retained deficit and reliance on equity financing remain important risks for investors.

  • Revenue growth remains strong. Q2 2026 revenue increased to $29.1 million from $24.2 million in Q2 2025 and $7.8 million in Q2 2024. Revenue has generally trended higher as the company has expanded its commercial operations.
  • Gross margins are favorable. Q2 2026 gross profit was $26.1 million, representing an approximately 89.7% gross margin. This was an improvement from roughly 86.3% in Q2 2025 and 80.5% in Q2 2024.
  • Operating profitability improved sharply in the latest quarter. Delcath reported operating income of $2.4 million in Q2 2026, compared with operating losses of $1.6 million in Q1 2026 and $2.2 million in Q4 2025. Net income was $2.7 million, or $0.07 per diluted share, versus losses in the prior two quarters.
  • Liquidity has strengthened considerably. At June 30, 2026, cash and short-term investments totaled approximately $95.9 million. Total current assets of $130.5 million substantially exceeded current liabilities of $13.3 million, providing a current ratio of roughly 9.8.
  • Operating cash flow turned meaningfully positive. Q2 2026 operating cash flow was $5.7 million, up from $0.9 million in Q1 2026 and well above the operating cash outflows reported during much of 2024. The company also generated a $6.2 million increase in cash during the quarter.
  • Leverage appears limited. Total liabilities were $15.9 million at the end of Q2 2026, compared with $121.1 million of equity. The balance sheet no longer shows the significant short- and long-term debt balances reported in 2023 and 2024.
  • Cash management is conservative but does not represent operating growth by itself. Delcath continues to move substantial amounts between cash and short-term investments. In Q2 2026, it purchased and sold approximately $32.3 million of investments, resulting in only a $0.5 million net investing cash outflow. These transactions support liquidity but should not be confused with investment returns or core-business cash generation.
  • Cash flow quality warrants monitoring. Q2 2026 operating cash flow exceeded reported net income partly because of $5.1 million in non-cash adjustments. Working-capital changes reduced operating cash flow by $1.8 million, indicating that future cash generation will depend on the persistence of earnings and effective management of receivables, inventory and accrued expenses.
  • The company still has a large accumulated deficit. Retained earnings were negative $527.3 million at June 30, 2026. Although recent quarters have included profits, Delcath has recorded substantial losses over its history and has not yet demonstrated consistent, multi-year profitability.
  • Share dilution remains a concern. Basic weighted-average shares outstanding rose to 35.9 million in Q2 2026 from 24.9 million in Q1 2024. The increase reflects prior equity financing and other share-related activity, which can reduce the per-share benefit of future earnings for existing investors.

Overall, the financial trend is improving: revenue is expanding, margins are high, the latest quarter was profitable and the balance sheet is well funded. The key questions for investors are whether Delcath can sustain operating profitability without relying heavily on non-cash adjustments and whether future growth can be financed without additional dilution.

10/20/26 07:38 AM ETAI Generated. May Contain Errors.

Delcath Systems Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Delcath Systems' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Over the last 10 years, Delcath Systems' net income changed from -$14.70 million in 2015 to $2.70 million in 2025. See where experts think Delcath Systems is headed by visiting Delcath Systems' forecast page.

Delcath Systems' total operating income in 2025 was $660 thousand, based on the following breakdown:
  • Total Gross Profit: $73.43 million
  • Total Operating Expenses: $72.77 million

Over the last 10 years, Delcath Systems' total revenue changed from $1.75 million in 2015 to $85.23 million in 2025, a change of 4,778.7%.

In the past 13 quarters, Delcath Systems' cash and equivalents has ranged from $8.32 million in Q3 2024 to $47.52 million in Q2 2026, and is currently $47.52 million as of their latest financial filing in Q2 2026.

Delcath Systems had total debt of $0.00 at the end of 2025, compared with none in 2024, and none in 2015.

Over the last 10 years, Delcath Systems' book value per share changed from 0.40 in 2015 to 3.15 in 2025, a change of 696.9%.



Financial statements for NASDAQ:DCTH last updated on 8/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners